Imatinib Not Yet Recruiting Phase 3 Trials for Gastrointestinal Stromal Tumors Diagnostic

IndicationsStatusPurposePhase
Not Yet RecruitingDiagnostic3
clinicaltrials.gov IdentifierTitleDrugs
NCT02576080Efficacy of Imatinib in Patients With Intermediate-risk Gastrointestinal Stromal Tumor With a High-risk Genomic Grade Index